7 unchanged sentences
The functional currency of our wholly owned foreign subsidiary, Barinthus Biotherapeutics Switzerland GmbH, is the Swiss franc.
−Removed: Our cash, cash equivalents and restricted cash as of September 30, 2025 consisted primarily of cash balances held by Barinthus Biotherapeutics (UK) Limited in United States dollars.
+Added: Our cash, cash equivalents and restricted cash as of March 31, 2026 consisted primarily of cash balances held by Barinthus Biotherapeutics (UK) Limited in United States dollars.
Assets and liabilities are translated into United States dollars at the exchange rate in effect on the balance sheet date.
2 unchanged sentences
Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in operating expenses, net in the condensed consolidated Statements of Operations and Comprehensive Loss as incurred.
−Removed: We incur significant operating costs in the United Kingdom and face exposure to changes in the exchange ratio of the United States dollar and the pound sterling arising from expenses and payables at our U.K.
+Added: We incur significant operating costs in the U.K.
+Added: and face exposure to changes in the exchange ratio of the United States dollar and the pound sterling arising from expenses and payables at our U.K.
operations that are settled in pound sterling.
−Removed: For the three and nine months ended September 30, 2025, an average 10% weakening in the United States dollar relative to the pound sterling would have resulted in a material change to our current and projected expenses denominated in pound sterling.
+Added: For the three months ended March 31, 2026, an average 10% weakening in the United States dollar relative to the pound sterling would have resulted in a material change to our current and projected expenses denominated in pound sterling.
Interest Rate Sensitivity
We are not currently exposed significantly to market risk related to changes in interest rates, as we have no significant interest-bearing liabilities.
−Removed: We had cash, cash equivalents and restricted cash of $75.7 million as of September 30, 2025, which were primarily held as account balances with banks in the United Kingdom, United States and Australia.
+Added: We had cash, cash equivalents and restricted cash of $67.2 million as of March 31, 2026, which were primarily held as account balances with banks in the U.K.
+Added: and United States.
A hypothetical 10% relative change in interest rates during any of the periods presented would not have had a material impact on our condensed consolidated financial statements.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.